Maa: Irlanti
Kieli: englanti
Lähde: HPRA (Health Products Regulatory Authority)
FINASTERIDE
Merck Sharp & Dohme Ireland (Human Health) Limited
G04CB01
FINASTERIDE
5 Milligram
Film Coated Tablet
Product subject to prescription which may not be renewed (A)
Testosterone-5-alpha reductase inhibitors
Authorised
2014-02-28
PACKAGE LEAFLET: INFORMATION FOR THE USER FINASTERIDE® 5 MG FILM-COATED TABLETS (FINASTERIDE) THIS MEDICINE IS FOR USE IN MEN ONLY READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TO TAKE THIS MEDICINE. • Keep this leaflet. You may want to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. What Finasteride is and what it is used for 2. Before you take Finasteride 3. How to take Finasteride 4. Possible side effects 5. How to store Finasteride 6. Further information 1. WHAT FINASTERIDE IS AND WHAT IT IS USED FOR 1. WHAT FINASTERIDE IS AND WHAT IT IS USED FOR Finasteride contains a medicine called finasteride. This belongs to a group of medicines called ‘5-alpha reductase inhibitors’. Finasteride shrinks the prostate gland in men when it is swollen. The prostate gland is found underneath the bladder (but only in men). It produces the fluid found in semen. A swollen prostate gland can lead to a condition called ‘benign prostatic hyperplasia’ or BPH. WHAT IS BPH? If you have BPH it means that your prostate gland is swollen. It can press on the tube that urine passes through, on its way out of your body. This can lead to problems such as: • feeling like you need to pass urine more often, especially at night • feeling that you must pass urine right away • finding it difficult to start passing urine • when you pass urine the flow of urine is weak • when you Lue koko asiakirja
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Finasteride 5mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of the active ingredient finasteride. Excipient: Each tablet contains 102mg lactose (as monohydrate). For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet (tablet). Blue, apple -shaped, tablets, marked ‘FINASTERIDE’ on one side and ‘MSD 72’ on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ‘Finasteride’ is indicated for the treatment and control of benign prostatic hyperplasia (BPH) and for the prevention of urologic events to: reduce the risk of acute urinary retention reduce the risk of surgery including transurethral resection of the prostate (TURP) and prostatectomy. ‘Finasteride’ causes regression of the enlarged prostate, improves urinary flow and improves the symptoms associated with BPH. Patients with an enlarged prostate are the appropriate candidates for therapy with ‘Finasteride’. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The recommended dosage is one 5 mg tablet daily, with or without food. 'Finasteride' can be administered alone or in combination with the alpha-blocker doxazosin (see section 5.1 'Pharmacodynamic properties'). Although early improvement in symptoms may be seen, treatment for at least six months may be necessary to assess whether a beneficial response has been achieved. The risk of acute urinary retention is reduced within four months of treatment. _Use in renal insufficiency_ No adjustment in dosage is required in patients with varying degrees of renal insufficiency (creatinine clearances as low as 9 ml/min), as pharmacokinetic studies did not indicate any change in the disposition of finasteride. _Use in the elderly_ Lue koko asiakirja